Aier Eye Hospital Group Co., Ltd.

SZSE:300015 Stock Report

Market Cap: CN¥126.9b

Aier Eye Hospital Group Future Growth

Future criteria checks 1/6

Aier Eye Hospital Group is forecast to grow earnings and revenue by 14.6% and 12.4% per annum respectively. EPS is expected to grow by 14.3% per annum. Return on equity is forecast to be 18.2% in 3 years.

Key information

14.6%

Earnings growth rate

14.3%

EPS growth rate

Healthcare earnings growth22.8%
Revenue growth rate12.4%
Future return on equity18.2%
Analyst coverage

Good

Last updated02 Dec 2024

Recent future growth updates

Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Fell Short of Analyst Expectations: Here's What You Need To Know

Apr 28
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Fell Short of Analyst Expectations: Here's What You Need To Know

Recent updates

Investors Could Be Concerned With Aier Eye Hospital Group's (SZSE:300015) Returns On Capital

Dec 17
Investors Could Be Concerned With Aier Eye Hospital Group's (SZSE:300015) Returns On Capital

Aier Eye Hospital Group (SZSE:300015) Has A Rock Solid Balance Sheet

Nov 16
Aier Eye Hospital Group (SZSE:300015) Has A Rock Solid Balance Sheet

Is Now The Time To Put Aier Eye Hospital Group (SZSE:300015) On Your Watchlist?

Oct 08
Is Now The Time To Put Aier Eye Hospital Group (SZSE:300015) On Your Watchlist?

Insufficient Growth At Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Hampers Share Price

Sep 09
Insufficient Growth At Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Hampers Share Price

Aier Eye Hospital Group (SZSE:300015) Has A Rock Solid Balance Sheet

Jul 28
Aier Eye Hospital Group (SZSE:300015) Has A Rock Solid Balance Sheet

Shareholders Are Optimistic That Aier Eye Hospital Group (SZSE:300015) Will Multiply In Value

Jul 12
Shareholders Are Optimistic That Aier Eye Hospital Group (SZSE:300015) Will Multiply In Value

Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Business Is Yet to Catch Up With Its Share Price

Jun 05
Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Business Is Yet to Catch Up With Its Share Price

Statutory Profit Doesn't Reflect How Good Aier Eye Hospital Group's (SZSE:300015) Earnings Are

May 02
Statutory Profit Doesn't Reflect How Good Aier Eye Hospital Group's (SZSE:300015) Earnings Are

Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Fell Short of Analyst Expectations: Here's What You Need To Know

Apr 28
Aier Eye Hospital Group Co., Ltd. (SZSE:300015) Fell Short of Analyst Expectations: Here's What You Need To Know

Calculating The Intrinsic Value Of Aier Eye Hospital Group Co., Ltd. (SZSE:300015)

Apr 02
Calculating The Intrinsic Value Of Aier Eye Hospital Group Co., Ltd. (SZSE:300015)

Many Would Be Envious Of Aier Eye Hospital Group's (SZSE:300015) Excellent Returns On Capital

Mar 15
Many Would Be Envious Of Aier Eye Hospital Group's (SZSE:300015) Excellent Returns On Capital

Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Shares May Have Run Too Fast Too Soon

Feb 29
Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Shares May Have Run Too Fast Too Soon

Earnings and Revenue Growth Forecasts

SZSE:300015 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202627,0845,0345,5256,79318
12/31/202524,1434,3634,6185,71820
12/31/202421,2553,8155,0805,61817
9/30/202420,6213,6292,8524,596N/A
6/30/202420,6613,6963,5335,346N/A
3/31/202420,5433,4773,8625,510N/A
12/31/202320,3673,3594,4125,872N/A
9/30/202319,1063,3484,4466,063N/A
6/30/202318,2542,9454,1395,544N/A
3/31/202316,9622,6953,7645,110N/A
1/1/202316,1102,5243,1024,491N/A
9/30/202216,4562,6773,4264,840N/A
6/30/202215,7602,4993,0674,488N/A
3/31/202215,6582,4502,8694,376N/A
1/1/202215,0012,3232,5904,084N/A
9/30/202114,9432,1812,6664,037N/A
6/30/202115,0962,1633,2634,586N/A
3/31/202113,7822,1283,0174,095N/A
12/31/202011,9121,7242,4503,344N/A
9/30/202010,8241,6942,1222,778N/A
6/30/20209,4051,3601,1121,751N/A
3/31/20209,3871,1609831,637N/A
12/31/20199,9901,3791,3332,078N/A
9/30/20199,6161,3451,2182,022N/A
6/30/20198,9781,1959031,619N/A
3/31/20198,5061,0916921,536N/A
12/31/20188,0091,0095891,400N/A
9/30/20187,7051,0058251,802N/A
6/30/20187,153890N/A1,690N/A
3/31/20186,512803N/A1,466N/A
12/31/20175,963743N/A1,330N/A
9/30/20175,300721N/A992N/A
6/30/20174,671646N/A873N/A
3/31/20174,283594N/A798N/A
12/31/20164,000557N/A775N/A
9/30/20163,807538N/A624N/A
6/30/20163,631499N/A630N/A
3/31/20163,429459N/A537N/A
12/31/20153,166428N/A522N/A
9/30/20153,006413N/A479N/A
6/30/20152,740367N/A480N/A
3/31/20152,535331N/A484N/A
12/31/20142,402309N/A454N/A
9/30/20142,316296N/A486N/A
6/30/20142,200266N/A428N/A
3/31/20142,091240N/A438N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300015's forecast earnings growth (14.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 300015's earnings (14.6% per year) are forecast to grow slower than the CN market (25.4% per year).

High Growth Earnings: 300015's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300015's revenue (12.4% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 300015's revenue (12.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300015's Return on Equity is forecast to be low in 3 years time (18.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 12:09
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aier Eye Hospital Group Co., Ltd. is covered by 45 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Siti Bte SalikinCFRA Equity Research
Songtao YEChangjiang Securities Co. LTD.